FILE:CVH/CVH-8K-20051107123907.txt.gz
EVENTS:	Regulation FD Disclosure	Financial Statements and Exhibits
TEXT:
ITEM: Regulation FD Disclosure
ITEM: Financial Statements and Exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported)
November 7, 2005
 
 
COVENTRY HEALTH CARE, INC.
(Exact name of registrant as specified in its charter).
 
 
 
6705 Rockledge Drive, Suite 900, Bethesda, Maryland 20817
(Address of principal executive offices) (Zip Code)
 
(301) 581-0600
(Registrant's telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
 
Precommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 24(b))
o
 
Precommencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 24(c))
o
 
 
 
 
SECTION 7  REGULATION FD
 
ITEM 7.01  Regulation FD Disclosure
 
On November 8, 2005 Coventry Health Care, Inc. will speak at the CIBC Healthcare Conference. The presentation for this meeting is furnished herewith as Exhibit 99.1
 
SECTION 9  FINANCIAL STATEMENT AND EXHIBITS
 
ITEM 9.01  Financial Statements and Exhibits
 
 
 
 
Signature
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
Exhibit Index
 
 
 
 
 
 
 
 

On November 8, 2005, management of Coventry will speak at the CIBC Healthcare Conference. The following is a series of slides used by Coventry management in the presentation.
Certain statements in this presentation will be forward-looking statements. Certain risks and uncertainties, including those in the Company's filings with the SEC, including its annual reports on Form 10-K, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Reconciliation of any non-GAAP measures discussed in this presentation will be posted on our Investor Relations website at www.cvty.com.
Q3 2005 - Solid Financial Results
Q3 2005 - Strong quality of earnings


